Research Article
Research of the Methylation Status of miR-124a Gene Promoter among Rheumatoid Arthritis Patients
Table 1
Clinical characteristics of the patients*.
| | Patient | Age | Sex | Disease duration (years) | Presurgical CRP (mg/dL) | Presurgical ESR (mm/h) | DAS 28 | Medications |
| | RA1 | 72 | F | 17 | 1.9 | 17 | 2.42 | MTX 10 mg qw
LEF 20 mg qd | | RA2 | 58 | F | 9 | 1.5 | 21 | 2.16 | MTX 12.5 mg qw
LEF 10 mg qd | | RA3 | 63 | M | 21 | 2.7 | 13 | 1.87 | Pred. 7.5 mg qd
MTX 12.5 mg qw | | RA4 | 65 | F | 15 | <1 | 2 | 1.21 | Pred. 5 mg qd
LEF 20 mg qd | | RA5 | 59 | M | 6 | 3.2 | 5 | 1.49 | Pred. 5 mg qod
MTX 10 mg qw | | RA6 | 66 | F | 8 | <1 | 9 | 1.23 | LEF 20 mg qd | | RA7 | 61 | F | 13 | 5.3 | 28 | 2.62 | MTX 15 mg qw | | OA1 | 72 | F | — | <1 | 3 | — | — | | OA2 | 75 | M | — | <1 | 2 | — | — | | OA3 | 69 | M | — | <1 | 4 | — | — | | OA4 | 74 | M | — | 3.3 | 9 | — | — | | OA5 | 68 | F | — | <1 | 3 | — | — | | OA6 | 70 | M | — | 2.8 | 11 | — | — | | C1 | 39 | M | — | | | | | | C2 | 45 | M | — | | | | | | C3 | 43 | F | — | | | | |
|
|
RA: rheumatoid arthritis; OA: osteoarthritis; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; DAS: disease activity score; MTX: methotrexate; Pred.: prednisone; LEF: leflunomides; C: control.
|
